Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tuberculosis, Lymph Node | 1 | 2017 | 27 | 0.72 | Why? |
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 97 | 0.66 | Why? |
| Mediastinum | 1 | 2017 | 122 | 0.66 | Why? |
| Abscess | 1 | 2017 | 234 | 0.58 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.48 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.43 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.36 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.24 | Why? |
| Nucleoside-Triphosphatase | 1 | 2020 | 18 | 0.22 | Why? |
| Salts | 1 | 2020 | 44 | 0.21 | Why? |
| Carcinoembryonic Antigen | 1 | 2021 | 140 | 0.21 | Why? |
| Bismuth | 1 | 2020 | 56 | 0.21 | Why? |
| Spermatogenesis | 1 | 2020 | 126 | 0.20 | Why? |
| Pyroptosis | 1 | 2021 | 168 | 0.19 | Why? |
| Macrophage Activation | 1 | 2021 | 315 | 0.19 | Why? |
| Cytochrome P-450 CYP3A Inhibitors | 1 | 2020 | 256 | 0.18 | Why? |
| Hypoalbuminemia | 1 | 2021 | 235 | 0.18 | Why? |
| Herpesvirus 1, Suid | 1 | 2017 | 18 | 0.17 | Why? |
| Chitinases | 1 | 2016 | 8 | 0.17 | Why? |
| Genes, Plant | 1 | 2016 | 42 | 0.16 | Why? |
| RNA Helicases | 1 | 2020 | 413 | 0.16 | Why? |
| Geologic Sediments | 1 | 2016 | 43 | 0.16 | Why? |
| Phosphorus | 1 | 2016 | 80 | 0.16 | Why? |
| Lakes | 1 | 2016 | 83 | 0.16 | Why? |
| Alternative Splicing | 1 | 2016 | 82 | 0.16 | Why? |
| Chemoprevention | 1 | 2021 | 585 | 0.15 | Why? |
| Neural Pathways | 1 | 2017 | 155 | 0.15 | Why? |
| Testis | 1 | 2020 | 566 | 0.15 | Why? |
| Lymph Node Excision | 1 | 2017 | 362 | 0.15 | Why? |
| Ritonavir | 2 | 2020 | 4212 | 0.14 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.14 | Why? |
| Tobacco | 1 | 2016 | 274 | 0.14 | Why? |
| Methyltransferases | 1 | 2020 | 720 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.13 | Why? |
| Nicotine | 1 | 2016 | 213 | 0.13 | Why? |
| Meta-Analysis as Topic | 1 | 2020 | 1289 | 0.13 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.12 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 800 | 0.12 | Why? |
| China | 15 | 2021 | 50654 | 0.12 | Why? |
| Macrophages | 2 | 2021 | 2784 | 0.12 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.11 | Why? |
| Water Pollutants, Chemical | 1 | 2016 | 410 | 0.11 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.11 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.10 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.10 | Why? |
| Blood Coagulation Disorders | 2 | 2020 | 2040 | 0.10 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.10 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.09 | Why? |
| Lopinavir | 2 | 2020 | 4308 | 0.09 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.09 | Why? |
| Lung | 3 | 2021 | 31049 | 0.08 | Why? |
| Middle Aged | 20 | 2021 | 270681 | 0.08 | Why? |
| Kidney | 2 | 2021 | 3648 | 0.08 | Why? |
| Infusions, Intravenous | 2 | 2020 | 1224 | 0.08 | Why? |
| Male | 22 | 2021 | 367725 | 0.07 | Why? |
| Pneumonia, Viral | 11 | 2021 | 243684 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Autopsy | 3 | 2021 | 3495 | 0.07 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Aged | 16 | 2021 | 215776 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.06 | Why? |
| Female | 19 | 2021 | 380317 | 0.06 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.06 | Why? |
| Models, Statistical | 1 | 2020 | 5312 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.06 | Why? |
| Critical Illness | 6 | 2021 | 17281 | 0.06 | Why? |
| Humans | 28 | 2021 | 930598 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.06 | Why? |
| Kinetics | 2 | 2020 | 3238 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Adult | 13 | 2021 | 244371 | 0.06 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 2309 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Adenosine Triphosphatases | 1 | 2020 | 78 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| THP-1 Cells | 1 | 2021 | 374 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Equivalence Trials as Topic | 1 | 2020 | 242 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Brain | 1 | 2017 | 5133 | 0.05 | Why? |
| Gene Ontology | 1 | 2020 | 391 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Cell Communication | 1 | 2021 | 396 | 0.05 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.05 | Why? |
| Double-Blind Method | 2 | 2020 | 5988 | 0.05 | Why? |
| Intention to Treat Analysis | 1 | 2020 | 673 | 0.04 | Why? |
| Telencephalon | 1 | 2017 | 4 | 0.04 | Why? |
| Epithelium | 1 | 2020 | 330 | 0.04 | Why? |
| Tyrosine 3-Monooxygenase | 1 | 2017 | 32 | 0.04 | Why? |
| Mesencephalon | 1 | 2017 | 12 | 0.04 | Why? |
| Eutrophication | 1 | 2016 | 10 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.04 | Why? |
| Paraventricular Hypothalamic Nucleus | 1 | 2017 | 21 | 0.04 | Why? |
| Ethylenes | 1 | 2016 | 12 | 0.04 | Why? |
| Fibrosis | 1 | 2021 | 800 | 0.04 | Why? |
| Plant Growth Regulators | 1 | 2016 | 20 | 0.04 | Why? |
| Muscle Weakness | 1 | 2021 | 406 | 0.04 | Why? |
| Oxylipins | 1 | 2016 | 29 | 0.04 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.04 | Why? |
| Cyclopentanes | 1 | 2016 | 55 | 0.04 | Why? |
| Spleen | 1 | 2021 | 877 | 0.04 | Why? |
| Blood Proteins | 1 | 2020 | 551 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.04 | Why? |
| Cyanobacteria | 1 | 2016 | 53 | 0.04 | Why? |
| Endothelium | 1 | 2020 | 460 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Lipid Metabolism | 1 | 2021 | 572 | 0.04 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2020 | 782 | 0.04 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.04 | Why? |
| Nomograms | 1 | 2021 | 790 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2021 | 1475 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Shock | 1 | 2020 | 1868 | 0.03 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2017 | 415 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Hospital Mortality | 3 | 2020 | 22087 | 0.03 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.03 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Radiography, Thoracic | 2 | 2020 | 5486 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.02 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.02 | Why? |
| Sleep Wake Disorders | 1 | 2021 | 1463 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Cells, Cultured | 1 | 2020 | 5835 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Animals | 3 | 2020 | 78931 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2016 | 3143 | 0.02 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Signal Transduction | 1 | 2016 | 7207 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 5002 | 0.01 | Why? |
| Genome, Viral | 1 | 2020 | 13157 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Mutation | 1 | 2016 | 12376 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.01 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Zhang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(200)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(455)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_